Get the Stockscreener App
0.63
0.24%
0.0015
After Hours:
.63
China Pharma Holdings Inc. stock is traded at $0.63, with a volume of 19,041.
It is up +0.24% in the last 24 hours and down -51.54% over the past month.
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, cephalosporin oral solutions, and granules. The company's products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Anhydroandrographolide for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; and Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. is headquartered in Haikou, the People's Republic of China.
See More
Previous Close:
$0.6285
Open:
$0.628
24h Volume:
19,041
Relative Volume:
0.37
Market Cap:
$3.16M
Revenue:
$5.54M
Net Income/Loss:
$-4.74M
P/E Ratio:
-1.875
EPS:
-0.336
Net Cash Flow:
$-750.60K
1W Performance:
+0.00%
1M Performance:
-51.54%
6M Performance:
-55.48%
1Y Performance:
-69.27%
1-Day Range:
$0.628
$0.6984
1-Week Range:
$0.628
$0.75
52-Week Range:
$0.6122
$3.18
China Pharma Holdings Inc. Stock (CPHI) Company Profile
Name
China Pharma Holdings Inc.
Sector
Phone
86 898 6681 1730
Address
No. 17, Jinpan Road, Second Floor, Haikou
Compare CPHI vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CPHI
China Pharma Holdings Inc.
|
0.63 | 3.16M | 5.54M | -4.74M | -750.60K | -0.336 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.37 | 57.75B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
125.64 | 56.70B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
11.16 | 49.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.92 | 39.96B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
476.13 | 20.49B | 3.13B | 1.27B | 1.12B | 26.39 |
China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-10 | Initiated | Rodman & Renshaw | Mkt Outperform |
China Pharma Holdings Inc. Stock (CPHI) Latest News
China Pharma to acquire patent through $8.82 million stock issuance By Investing.com - Investing.com UK
China Pharma to acquire patent through $8.82 million stock issuance - Investing.com
China Pharma Acquires Topiroxostat Patent Via Equity Issuance - TipRanks
Risk Check: Is PGEN stock a hidden gemPortfolio Risk Summary & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Aug Reactions: Can China Pharma Holdings Inc stock outperform in a bear marketJuly 2025 Spike Watch & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Ascentage Pharma Group International Announces IND Clearance by the China CDE for BTK Degrader APG-3288 - marketscreener.com
Ascentage Pharma Announces IND Clearance by the China CDE for BTK Degrader APG-3288 - Yahoo Finance
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
DSS, INC. (DSS) - MSN
Risk Off: Is GPATW part of any major index2025 Major Catalysts & Daily Oversold Bounce Ideas - baoquankhu1.vn
12 Health Care Stocks Moving In Monday's After-Market Session - Sahm
China Pharma Holdings acquires patent in stock deal - MSN
What China SXT's 1-for-150 share consolidation means for holders - Stock Titan
Trading Recap: Is Suncor Energy Inc benefiting from interest rate changesBond Market & Weekly High Return Forecasts - baoquankhu1.vn
Boehringer Ingelheim in deal with China's Simcere Pharma to license IBD drug candidate - Yahoo Finance
Bear Alert: Does ALHC align with a passive investing strategyJuly 2025 Price Swings & AI Powered Market Entry Strategies - baoquankhu1.vn
Resistance Check: Can China Pharma Holdings Inc expand its profit marginsTrade Exit Summary & Weekly High Return Stock Forecasts - baoquankhu1.vn
China halts sale of Sun Pharma drug used to treat dementia - Yahoo Finance
Merck KGaA (OTCMKTS:MKGAF) versus China Pharma (NYSE:CPHI) Financial Contrast - Defense World
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Rally Mode: Will Century Casinos Inc benefit from geopolitical trendsRisk Management & Growth Oriented Trade Recommendations - baoquankhu1.vn
Ascentage Pharma Group International (OTCMKTS:ASPHF) Sees Significant Increase in Short Interest - Defense World
Can Bitcoin Depot Inc. deliver consistent dividendsWeekly Stock Analysis & Weekly Watchlist for Hot Stocks - bollywoodhelpline.com
Fed Meeting: How do insiders feel about National Health Investors IncMarket Performance Summary & Weekly High Momentum Picks - baoquankhu1.vn
ETF Watch: Can China Pharma Holdings Inc expand its profit margins - baoquankhu1.vn
Retail Trends: Does GNSS have strong fundamentalsEarnings Summary Report & Precise Buy Zone Identification - baoquankhu1.vn
Aug Levels: Will CHRW outperform its industry peersMarket Growth Review & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Pharma News: Can NI Holdings Inc stock double in the next year2025 Major Catalysts & Smart Investment Allocation Tips - baoquankhu1.vn
Will Westlake Corporation announce a stock splitM&A Rumor & Safe Capital Growth Plans - bollywoodhelpline.com
Wyndham Enhances Position in South Korea with First Managed Hotel Opening - digitalmore.co
How much upside does Apple Hospitality REIT Inc havePortfolio Profit Report & Low Risk Entry Point Guides - baoquankhu1.vn
Why China Pharma Holdings Inc. stock is seen as undervaluedTrade Risk Summary & Growth Focused Entry Point Reports - ulpravda.ru
Will China Pharma Holdings Inc. stock rise with strong economy2025 Macro Impact & Weekly Return Optimization Plans - ulpravda.ru
Price Clustering Detected in Robust Hotels Limited StockInsider Buying Signals & Low Risk Capital Growth - Bollywood Helpline
Published on: 2026-01-09 04:04:30 - Улправда
ARS Pharma (SPRY) Gains China Approval for Neffy, Roth Reiterates Buy Rating - Yahoo Finance
Bhakti Gems and Jewellery Limited Flashes Buy Signal on Multi Timeframe ChartWeekly Profit Summary & Expert-Curated Trade Recommendations - Улправда
What dividend safety score for China SXT Pharmaceuticals Inc. stockJuly 2025 Update & Reliable Intraday Trade Plans - Улправда
Why SPDW stock remains top ratedJuly 2025 Outlook & Daily Chart Pattern Signal Reports - Улправда
2026 world cup canada quarterfinals defensive leaders low block group prediction previewPortfolio Gains Summary & AI Powered Buy and Sell Recommendations - Улправда
What sentiment indicators say about China Pharma Holdings Inc. stockJuly 2025 Review & Fast Entry Momentum Alerts - Улправда
How China Pharma Holdings Inc. stock reacts to Fed rate cutsWeekly Stock Report & Daily Volume Surge Signals - Улправда
Pharma News: How China Foods Limited (CFH) stock reacts to stronger dollar2025 Geopolitical Influence & Verified Trade Idea Suggestions - ulpravda.ru
BC-Most Active Stocks - WFMZ.com
Bollinger Bands Expand on Shrydus Industries Limited — Volatility AheadVolume Weighted Average Price & Budget Friendly Investment Plans - bollywoodhelpline.com
Will China Pharma Holdings Inc. stock benefit from automation2025 Key Highlights & Weekly High Momentum Picks - Улправда
CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC AI INSIGHTS INITIATIVE TO OPTIMIZE TRADITIONAL CHINESE MEDICINE PORTFOLIO, ENHANCE MARKET ANALYSIS AND EXPLORE AI-SUPPORTED CLINIC DEPLOYMENT - Yahoo Finance
Pharma News: Can ELL Environmental Holdings Limited 6EL stock beat S P 500 performance this year2025 Trade Ideas & High Return Trade Opportunity Guides - Bộ Nội Vụ
China Pharma shareholders approve director elections and reverse stock split authorization By Investing.com - Investing.com India
China Pharma shareholders approve director elections and reverse stock split authorization - Investing.com Australia
China Pharma stockholders approve reverse split, governance changes - TipRanks
China Pharma Holdings Inc. Stock (CPHI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.70%
10.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):